ARCHIVES

Clolar Approved for Pediatric Refractory/Relapsed ALL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

The Varmus Era: Controversy Continues

January 6, 1995

In Brief: Jordan To Join MD Anderson Cancer Center

July 25, 2014

Cancer Policy; Board Suggests More Detailed Items In Tobacco Agreement

August 22, 1997

ASCO Ends Early Distribution Of Abstracts To Halt “ASCO Effect” On Stock Market

January 24, 2003

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

July 28, 2000

Oregon Center Launching $1 Billion Program To Identify Lethal Cancers Before They Kill

May 9, 2014